Location History:
- Tucson, AZ (US) (2010)
- Tampa, FL (US) (2016 - 2023)
Company Filing History:
22 out of 290 
11 out of 972 
7 out of 1,933 
Years Active: 2010-2025
Title: Innovations and Contributions of Robert J Gillies
Introduction: Robert J Gillies, based in Tucson, Arizona, is an accomplished inventor with a remarkable portfolio of 24 patents. His innovative work spans multiple fields, particularly in medical research and imaging technologies. Gillies' contributions aim to enhance therapeutic strategies and diagnostic capabilities in addressing complex health challenges.
Latest Patents: Among his notable patents, Gillies has developed ligands for the melanocortin 1 receptor (MC1R) as well as methods utilizing these unique peptides. His invention of modified MC1R peptide ligands enables targeted delivery of therapeutic agents to melanoma tumor cells. This innovation incorporates a click functionality for conjugation purposes, allowing for the precise targeting of cancer cells, potentially improving the efficacy of anti-cancer drugs.
In another patent, Gillies introduces a multi-initialization ensemble-based defense strategy against adversarial attacks in medical imaging systems. This method involves multiple conventional neural networks, trained on both original and adversarially altered image datasets, to enhance the reliability of medical image classification. By aggregating outputs from various networks, the strategy improves the accuracy of categorizing modified input images, making significant strides in protective measures for medical imaging processes.
Career Highlights: Throughout his career, Robert J Gillies has been affiliated with distinguished institutions such as the H. Lee Moffitt Cancer Center and Research Institute and the Arizona Board of Regents on behalf of the University of Arizona. His tenure at these organizations has solidified his reputation as a leading innovator in cancer research and medical technology.
Collaborations: Gillies has collaborated with prominent professionals in the field, including David L Morse and Josef Vagner, further enhancing the scope and impact of his research. These partnerships have facilitated the development of groundbreaking technologies and solutions that aim to address critical issues in medical science.
Conclusion: With a strong foundation in medical research and a dedication to innovation, Robert J Gillies continues to contribute significantly to the advancement of cancer treatment and medical imaging. His patent portfolio reflects a commitment to improving patient care and diagnostic accuracy, ensuring that his work will have lasting implications in the field.